Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-02-20 @ 6:05 PM
Study NCT ID:
NCT02739633
Status:
UNKNOWN
Last Update Posted:
2018-04-18
First Post:
2016-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
Sponsor:
Samyang Biopharmaceuticals Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Genexol-PM PC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None